Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2021 financial results on Monday, November 8, 2021, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.
After delivering enormous gains in 2020, the collection of exchange-traded funds or ETFs Cathie Wood manages for ARK Invest have underperformed this year. It's probably a little too early to know if 2020 was a once-in-a-lifetime event for ARK Invest ETFs. Teladoc Health (NYSE: TDOC), Coinbase Global (NASDAQ: COIN), and Invitae (NYSE: NVTA) are reporting soon.
Invitae (NYSE: NVTA), University College London (UCL), and the Francis Crick Institute today announced new data from their TRACERx lung cancer research collaboration funded by Cancer Research UK and sponsored by UCL. The data, presented by Professor Charles Swanton of UCL and the Francis Crick Institute at the International Society of Liquid Biopsy (ISLB) Congress, further validate the value of liquid biopsy as a less invasive and more comprehensive approach to guiding personalized cancer treatm